Table 1.
Demographic and clinical characteristics of the four T2DM cohorts identified during the accrual period (2015).
| Variable | T2DM patients with CAD and/or stroke (cohort #1) n=33,153 | T2DM patients without CAD or stroke (cohort #2) n=407,932 | T2DM patients with CAD, but no MI or stroke (cohort #3) n=19,787 | T2DM patients with CAD and PCI, but no MI or stroke (cohort #4) n=2166 |
|---|---|---|---|---|
| Age, years (mean ± SD) | 73 ± 10 | 67 ± 14 | 73 ± 10 | 70 ± 9 |
| Women (%) | 35.1 | 51.3 | 33.8 | 26.3 |
| Clinical characteristics (% patients in the cohort) | ||||
| Arterial hypertension | 93.8 | 69.8 | 94.2 | 96.0 |
| Dyslipidemia | 76.2 | 46.3 | 76.1 | 89.1 |
| Chronic lung diseases | 22.1 | 10.4 | 23.1 | 16.3 |
| Depression | 14.4 | 11.2 | 13.4 | 10.3 |
| Heart failure | 13.3 | 1.4 | 12.5 | 10.9 |
| Chronic kidney diseases | 11.5 | 2.2 | 11.0 | 8.4 |
| Neoplasia | 9.2 | 5.9 | 9.8 | 7.7 |
| Atrial fibrillation | 9.2 | 1.2 | 7.9 | 5.2 |
| Severe liver diseases | 2.7 | 1.6 | 2.9 | 2.1 |
p Values for group comparisons <0.001 for all variables.
CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; SD, standard deviation; T2DM, type 2 diabetes mellitus.